science

Idarucizumab

Idarucizumab is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Idarucizumab rather than just read about it. In short: Idarucizumab, sold under the brand name Praxbind, is a monoclonal antibody used as a reversal agent for dabigatran. Idarucizumab was developed by Boehringer Ingelheim.

Key takeaways

Idarucizumab belongs to science; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect Idarucizumab to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of Idarucizumab from memory before moving on to harder problems.

Reference excerpt

Idarucizumab, sold under the brand name Praxbind, is a monoclonal antibody used as a reversal agent for dabigatran. Idarucizumab was developed by Boehringer Ingelheim. One study sponsored by the manufacturer found that idarucizumab effectively reversed anticoagulation caused by dabigatran within minutes. It was approved for medical use in the United States and in the European Union in 2015.

Mechanism of action Idarucizumab is a non-competitive inhibitor that forms complexes with dabigatran to counteract its anticoagulant effect within minutes of administration. It binds to dabigatran that is free or bound to thrombin, as well as dabigatran's active metabolites. Idarucizumab is specific to dabigatran and has an affinity that is around 350 times stronger compared to thrombin.

Medical uses A systematic review found that idarucizumab was most frequently given to patients on dabigatran who were experiencing bleeding. It was also prescribed to patients before undergoing invasive surgery. The most common dose of idarucizumab prescribed was 5 g. This is consistent with the current guidelines in the USA and Canada regarding the use and indications of idarucizumab. A second dose of idarucizumab may be administered if bleeding is still present, or if another invasive surgery is needed after the initial 5 g dose. However, there is much less evidence on the benefits and harms of a repeated dose, and it is rarely given.

Adverse effects The most common minor adverse effect was headache. Other side effects include back pain, skin irritation, constipation and weakness. A major adverse effect is thromboembolism resulting in stroke, pulmonary embolism, deep vein thrombosis and heart attack. This is especially of concern, because patients prescribed idarucizumab were already at a higher risk of thromboembolic events.

Pregnancy There are no human or animal studies that show the effect of idarucizumab in pregnancy and lactation. Idarucizumab, if indicated, may be taken during pregnancy, due to the benefits it provides to the patient compared to the unclear risk to the fetus.

Society and culture

Names Idarucizumab is the International nonproprietary name (INN). The description was updated in 2016. Idarucizumab is the United States Adopted Name (USAN).

References

Worked examples

Example 1 — a first encounter with Idarucizumab

Start with the simplest possible case. Write down what Idarucizumab claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Idarucizumab before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Idarucizumab ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Idarucizumab

In research: Idarucizumab appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses Idarucizumab in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: Idarucizumab is common in secondary-school and first-year university syllabi. It links to neighbouring topics Antidotes, Drugs developed by Boehringer Ingelheim, Monoclonal antibodies, so understanding it makes those chapters shorter.
In everyday life: Look for Idarucizumab outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Idarucizumab” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Idarucizumab in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what Idarucizumab means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain Idarucizumab out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Idarucizumab in simple terms?

Idarucizumab, sold under the brand name Praxbind, is a monoclonal antibody used as a reversal agent for dabigatran. Idarucizumab was developed by Boehringer Ingelheim.

Why does Idarucizumab matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Idarucizumab?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Idarucizumab.